Remarkably, the expression of these factors is elevated in the brains of PD patients as well; αSYN aggregates being the most likely pathological ligand of TLR2 whose expression is tightly linked to PD pathogenesis [26–28], suggesting that they may act in concert to shape microglial activation into a unique disease phenotype. This evidence concerns the gene TLR2 and Parkinson disease.